Archon Biosciences

Archon Biosciences is a biotechnology company developing a class of biologics called Antibody Cages (AbCs), designed to tackle therapeutic targets. Utilizing computational protein design, it engineers AbCs with precise control over structure, size, and binding functionality, resulting in targeting and biodistribution for improved therapeutic outcomes. Integrating antibody specificity with innovative protein design offers new solutions for previously inaccessible pathways.